Business
Datavault AI Goes From Under the Radar to Fully Armed with Capital, Credibility, and Commitment
BEAVERTON, OR / ACCESS Newswire / September 29, 2025 / Datavault AI (NASDAQ:DVLT) is no longer a quiet name drifting under the surface of the market. In the
About this update from Datavault Ai Inc.
[{"type":"text","content":"BEAVERTON, OR / ACCESS Newswire / September 29, 2025 / Datavault AI (NASDAQ:DVLT) is no longer a quiet name drifting under the surface of the market. In the span of a week, the company has stacked a series of moves that turn it from a misunderstood microcap into one of the most compelling growth stories in AI.First came the $150 million strategic investment from Scilex. Then came the amended subscription agreement with IBM, giving Datavault capital flexibility to grow instead of prepaying for services. And on Monday, the company announced a multi-million-dollar commitment from IBM, including its resources such as engineering, technical sales, and quantum expertise to accelerate Datavault's platform build and go-to-market initiatives. Together, these three catalysts are reshaping the company's trajectory.And when broken down further, it's understandable why investors have bid DVLT shares to $1.16 so far in September, about 241% higher from where they started the month.A Transformative Investment from ScilexThe Scilex deal was the kind that changes balance sheets overnight. The bank account was fortified, growth projects funded, and the company's strategic trajectory reset in one stroke. But more than capital, Scilex brought industry reach. As a biotech heavyweight with a current market cap of over $185 million, Scilex plugged Datavault directly into one of the most data-hungry sectors in the world.Genomics, clinical trials, pharmaceuticals, and all biotech, for that matter, generate vast amounts of data that are desperate for authentication and monetization. With Scilex, Datavault secured both the money and the vertical access to prove its model in one of the toughest proving grounds imaginable: biotech. If that was the balance sheet reset, the IBM amendment was the financial engine tune-up.The original subscription deal with IBM gave Datavault access to watsonX AI and cloud services, but it came with heavy upfront payments. The September 22nd amendment, disclosed in a Form 8-K, flipped the script. Datavault now pays $2.5 million toward the prior commitments and then spreads the balance across a $3.3 million installment due in December 2025, followed by eight quarterly payments of $2.18 million through the end of 2027.That means Datavault can instead funnel resources into scaling exchanges, onboarding clients, and accelerating re...